ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of 41.69 billion. The enterprise value is 43.15 billion.

Market Cap	41.69B
Enterprise Value	43.15B

Important Dates

The next estimated earnings date is Thursday, August 1, 2024.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	May 8, 2024

Share Statistics

ResMed has 1.47 billion shares outstanding. The number of shares has increased by 0.04% in one year.

Shares Outstanding	1.47B
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	10.98%
Float	n/a

Valuation Ratios

The trailing PE ratio is 28.91 and the forward PE ratio is 23.87. ResMed's PEG ratio is 1.79.

PE Ratio	28.91
Forward PE	23.87
PS Ratio	6.29
PB Ratio	6.02
P/FCF Ratio	33.26
PEG Ratio	1.79

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.69, with an EV/FCF ratio of 34.34.

EV / Earnings	30.03
EV / Sales	6.49
EV / EBITDA	18.69
EV / EBIT	21.60
EV / FCF	34.34

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.25.

Current Ratio	3.04
Quick Ratio	1.34
Debt / Equity	0.25
Debt / EBITDA	0.76
Debt / FCF	1.39
Interest Coverage	-40.76

Financial Efficiency

Return on equity (ROE) is 20.70% and return on invested capital (ROIC) is 16.76%.

Return on Equity (ROE)	20.70%
Return on Assets (ROA)	14.06%
Return on Capital (ROIC)	16.76%
Revenue Per Employee	655,259
Profits Per Employee	141,689
Employee Count	10,140
Asset Turnover	0.69
Inventory Turnover	3.73

Taxes

In the past 12 months, ResMed has paid 335.86 million in taxes.

Income Tax	335.86M
Effective Tax Rate	18.95%

Stock Price Statistics

The stock price has decreased by -13.87% in the last 52 weeks. The beta is 0.69, so ResMed's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-13.87%
50-Day Moving Average	31.41
200-Day Moving Average	27.18
Relative Strength Index (RSI)	35.52
Average Volume (20 Days)	2,049,490

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ResMed had revenue of 6.64 billion and earned 1.44 billion in profits. Earnings per share was 0.96.

Revenue	6.64B
Gross Profit	3.74B
Operating Income	1.80B
Pretax Income	1.76B
Net Income	1.44B
EBITDA	2.31B
EBIT	2.00B
Earnings Per Share (EPS)	0.96

Full Income Statement

Balance Sheet

The company has 356.66 million in cash and 1.75 billion in debt, giving a net cash position of -1.36 billion or -0.93 per share.

Cash & Cash Equivalents	356.66M
Total Debt	1.75B
Net Cash	-1.36B
Net Cash Per Share	-0.93
Equity (Book Value)	6.94B
Book Value Per Share	4.72
Working Capital	2.37B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.43 billion and capital expenditures -178.06 million, giving a free cash flow of 1.26 billion.

Operating Cash Flow	1.43B
Capital Expenditures	-178.06M
Free Cash Flow	1.26B
FCF Per Share	0.85

Full Cash Flow Statement

Margins

Gross margin is 56.36%, with operating and profit margins of 27.09% and 21.62%.

Gross Margin	56.36%
Operating Margin	27.09%
Pretax Margin	26.48%
Profit Margin	21.62%
EBITDA Margin	34.74%
EBIT Margin	30.06%
FCF Margin	18.91%

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 1.01%.

Dividend Per Share	0.29
Dividend Yield	1.01%
Dividend Growth (YoY)	9.09%
Years of Dividend Growth	5
Payout Ratio	29.96%
Buyback Yield	-0.04%
Shareholder Yield	0.97%
Earnings Yield	3.44%
FCF Yield	3.01%

Dividend Details

Analyst Forecast

Price Target	34.42
Price Target Difference	21.28%
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 12, 2010. It was a forward split with a ratio of 2:1.

Last Split Date	Aug 12, 2010
Split Type	Forward
Split Ratio	2:1